These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 19917992)

  • 1. Study of 962 patients indicates progressive muscular atrophy is a form of ALS.
    Kim WK; Liu X; Sandner J; Pasmantier M; Andrews J; Rowland LP; Mitsumoto H
    Neurology; 2009 Nov; 73(20):1686-92. PubMed ID: 19917992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential motor neuron involvement in progressive muscular atrophy: a comparative study with amyotrophic lateral sclerosis.
    Riku Y; Atsuta N; Yoshida M; Tatsumi S; Iwasaki Y; Mimuro M; Watanabe H; Ito M; Senda J; Nakamura R; Koike H; Sobue G
    BMJ Open; 2014 May; 4(5):e005213. PubMed ID: 24833696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive Muscular Atrophy.
    Liewluck T; Saperstein DS
    Neurol Clin; 2015 Nov; 33(4):761-73. PubMed ID: 26515620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of the prevalence and incidence of motor neuron diseases in two Spanish regions: Catalonia and Valencia.
    Barceló MA; Povedano M; Vázquez-Costa JF; Franquet Á; Solans M; Saez M
    Sci Rep; 2021 Mar; 11(1):6207. PubMed ID: 33737526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
    Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
    Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of young-adult amyotrophic lateral sclerosis.
    Sabatelli M; Madia F; Conte A; Luigetti M; Zollino M; Mancuso I; Lo Monaco M; Lippi G; Tonali P
    Neurology; 2008 Sep; 71(12):876-81. PubMed ID: 18596241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-term prospective study of the natural course of sporadic adult-onset lower motor neuron syndromes.
    Van den Berg-Vos RM; Visser J; Kalmijn S; Fischer K; de Visser M; de Jong V; de Haan RJ; Franssen H; Wokke JH; Van den Berg LH
    Arch Neurol; 2009 Jun; 66(6):751-7. PubMed ID: 19506135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history and clinical features of the flail arm and flail leg ALS variants.
    Wijesekera LC; Mathers S; Talman P; Galtrey C; Parkinson MH; Ganesalingam J; Willey E; Ampong MA; Ellis CM; Shaw CE; Al-Chalabi A; Leigh PN
    Neurology; 2009 Mar; 72(12):1087-94. PubMed ID: 19307543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progressive muscle atrophy. A rarely diagnosed variant of amyotrophic lateral sclerosis].
    Meyer T; Münch C; van Landeghem FK; Borisow N; Dullinger J; Linke P
    Nervenarzt; 2007 Dec; 78(12):1383-8. PubMed ID: 17516042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-sectional and longitudinal assessment of the upper cervical spinal cord in motor neuron disease.
    van der Burgh HK; Westeneng HJ; Meier JM; van Es MA; Veldink JH; Hendrikse J; van den Heuvel MP; van den Berg LH
    Neuroimage Clin; 2019; 24():101984. PubMed ID: 31499409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural history of primary lateral sclerosis.
    Gordon PH; Cheng B; Katz IB; Pinto M; Hays AP; Mitsumoto H; Rowland LP
    Neurology; 2006 Mar; 66(5):647-53. PubMed ID: 16534101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor neuron diseases in the university hospital of Fortaleza (Northeastern Brazil): a clinico-demographic analysis of 87 cases.
    Castro-Costa CM; Oriá RB; Vale OC; Arruda JA; Horta WG; D'Almeida JA; Santos TJ; Ramos RS; Gifoni MA
    Arq Neuropsiquiatr; 2000 Dec; 58(4):986-9. PubMed ID: 11105062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncovering amyotrophic lateral sclerosis phenotypes: clinical features and long-term follow-up of upper motor neuron-dominant ALS.
    Sabatelli M; Zollino M; Luigetti M; Grande AD; Lattante S; Marangi G; Monaco ML; Madia F; Meleo E; Bisogni G; Conte A
    Amyotroph Lateral Scler; 2011 Jul; 12(4):278-82. PubMed ID: 21702734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical profile of motor neuron disease patients with lower urinary tract symptoms and neurogenic bladder.
    Vázquez-Costa JF; Arlandis S; Hervas D; Martínez-Cuenca E; Cardona F; Pérez-Tur J; Broseta E; Sevilla T
    J Neurol Sci; 2017 Jul; 378():130-136. PubMed ID: 28566149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of upper and lower motor neuron burden on diagnostic certainty, and clinical course of spinal-onset amyotrophic lateral sclerosis: a cluster-based approach.
    Milella G; Zoccolella S; Giugno A; Filardi M; Urso D; Nigro S; Tafuri B; Tamburrino L; Gnoni V; Logroscino G
    J Neurol; 2023 Oct; 270(10):4868-4875. PubMed ID: 37338613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive dysfunction in lower motor neuron disease: executive and memory deficits in progressive muscular atrophy.
    Raaphorst J; de Visser M; van Tol MJ; Linssen WH; van der Kooi AJ; de Haan RJ; van den Berg LH; Schmand B
    J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):170-5. PubMed ID: 20562407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the nigrosome 1 absence as a biomarker in amyotrophic lateral sclerosis.
    Moreno-Gambín MI; Tembl JI; Mazón M; Cañada-Martínez AJ; Martí-Bonmatí L; Sevilla T; Vázquez-Costa JF
    J Neurol; 2022 Mar; 269(3):1631-1640. PubMed ID: 34379200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS.
    Ince PG; Evans J; Knopp M; Forster G; Hamdalla HH; Wharton SB; Shaw PJ
    Neurology; 2003 Apr; 60(8):1252-8. PubMed ID: 12707426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive and behavioural changes in PLS and PMA:challenging the concept of restricted phenotypes.
    de Vries BS; Rustemeijer LMM; Bakker LA; Schröder CD; Veldink JH; van den Berg LH; Nijboer TCW; van Es MA
    J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):141-147. PubMed ID: 30076267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS.
    Mitsumoto H; Ulug AM; Pullman SL; Gooch CL; Chan S; Tang MX; Mao X; Hays AP; Floyd AG; Battista V; Montes J; Hayes S; Dashnaw S; Kaufmann P; Gordon PH; Hirsch J; Levin B; Rowland LP; Shungu DC
    Neurology; 2007 Apr; 68(17):1402-10. PubMed ID: 17452585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.